We performed a prospective, randomized study in 55 ASA 1 to 3 women undergoing elective gynaecological surgery followed by postoperative epidural analgesia. We compared the incidence of bacterial colonization at the epidural exit site following catheter removal between a control group and an experimental group who received a chlorhexidine impregnated dressing (Biopatch, Johnson and Johnson, Arlington, TX, U.S.A.). Positive culture results were found in 11 of 27 (40.1%) patients in the control group compared with one of 29 (3.4%) patients whose epidural catheters were dressed with the Biopatch. We concluded that the Biopatch was effective in reducing bacterial colonization of the epidural catheter exit site.
The reported incidence of epidural abscess following epidural anaesthesia varies enormously but may be increasing. Not only do cases of epidural abscess or meningitis appear to be reported more frequently 1 , but recent reports have suggested an incidence of between one in 1930 and one in 5000 epidural abscesses per epidural catheter 2, 3 .
One of the numerous mechanisms that have been proposed for the development of epidural space infections in association with epidural catheters is the migration of bacteria from the skin along the catheter. Support for this mechanism is found in a review of 35 epidural abscesses with positive bacterial culture, which identified a Staphylococcus species in 83% of cases 3 .
In patients with central venous catheters, bacterial colonization of the skin entry site is significantly correlated with catheter colonization and septi-caemia 4 . The antiseptic used to clean the skin 5 or the applied dressing 6 influence the incidence of septicaemia.
The Biopatch Antimicrobial Dressing (Johnson and Johnson, Arlington, TX, U.S.A.) is a hydrophilic polyurethane absorptive foam dressing impregnated with chlorhexidine gluconate, designed to release chlorhexidine and inhibit bacterial growth for greater than seven days. It has been shown to significantly reduce bacterial colonization of central venous catheter sites 7 . A previous study using a similar dressing demonstrated a significant reduction in microbial colonization of epidural catheters 8 .
We report a prospective randomized trial performed to determine whether the use of the Biopatch reduced the incidence of bacterial colonization of the epidural exit site.
METHODS
Following Ethics Committee approval and written informed patient consent, 74 women undergoing elective gynaecological surgery, where insertion of an epidural catheter was planned, were randomly allocated according to a computer generated set of random numbers to either a control or study group. Consultant anaesthetists or trainee registrars inserted the epidural catheters using an aseptic technique involving gown, gloves, cap and mask. The skin was prepared with 0.5% chlorhexidine in 70% alcohol. This paper was presented in part at the 1998 Winter Scientific Meeting of the West Australian Branch of the Australian and New Zealand College of Anaesthestists.
The catheter was secured with a transparent dressing (Tegaderm, 3M Health Care, St Paul, MN, U.S.A.) in both groups and the only procedural difference between the study and control groups was the addition of the Biopatch dressing at the exit site in the study group. Insertion details were recorded and data were collected on technique (combined spinal epidural (CSE) or epidural), location (thoracic or lumbar), operator experience (trainee or consultant) and difficulty of insertion (single skin puncture or more than one skin puncture). The presence of diabetes or treatment with steroids was also noted.
An anaesthetic registrar, who could not be blinded as the Biopatch could be seen through the transparent dressing, reviewed all patients daily. Following removal of the epidural catheter the epidural exit site was inspected and the exit hole swabbed with a fine 2 mm diameter cotton tipped wire swab (Copan Italia, Interpath Services, Victoria, Australia). This was placed in Amies charcoal transport medium for transport to microbiology for culture. After arrival in the laboratory and no more than 12 hours after collection, the distal 2 cm of the swab was cut off and vigorously shaken for 15 seconds in 2 ml of 3% trypticase soya broth (Oxoid Ltd, Victoria, Australia). Twenty microlitres of this solution was subsequently plated onto 5% horse blood agar for 24 hours aerobic incubation. Colony identification was performed using standard protocols 9 . Bacterial counts were reported semi-quantitatively (i.e., 1000 colony forming units (cfu)/ml, 10,000 cfu/ml, 100,000 cfu/ml or >100,000 cfu/ml). A positive swab culture was defined as greater than or equal to 100 cfu/ml.
A pilot study of 20 patients at the hospital determined a 70% incidence of microbial colonization using the above parameters at the epidural exit site after use of a standard dressing (Tegaderm, 3M Healthcare, Borken, Germany). Power analysis indicated that detection of a reduction in the positive microbial culture rate from 70% to 15% with an alpha of 0.05 and beta of 0.1, required a sample size of 50. All non-parametric data were analysed using the chi squared test or two-tailed Fisher exact test if one of the cells had a very small expected count.
RESULTS
Of the 74 patients initially recruited, 19 (10 in the Biopatch group and 9 in the control group) were excluded due to removal of the epidural catheter without the epidural exit site being swabbed. As a result, data from 55 patients were included in the analysis (control group n=26, Biopatch group n=29).
Mean patient age was 50.8 (SD 16.1) years in the Biopatch group and 52.4 (SD 13.3) years in the control group. There were five patients with diabetes and one patient receiving steroids in the Biopatch group compared to one patient with diabetes and one patient on steroids in the control group.
Overall 11 of 26 (42.3%) control patients had evidence of microbial colonization compared with one of 29 (3.45%) patients in whom the Biopatch was used (P=0.001).
Coagulase negative staphylococci were isolated in seven patients, Staphylococcus aureus in four and Enterococcus species in one patient. In addition, Enterococcus species were grown as a second organism in three patients. A breakdown of the number of colony-forming units of the various bacteria is shown in Table 1 .
There was a significant difference in the number of epidural catheters placed in each group by consultants and trainees, with consultants placing a significantly greater proportion in the Biopatch group. Epidural catheters were left in place longer in the Biopatch group (Table 2 ).
An analysis of other risk factors that may affect bacterial colonization rate of the exit site is presented for the control group in Table 3 .
Two patients in the control group developed symptoms of meningism with neck stiffness, raised white cell count (WCC) and fever in the postoperative period. Cerebrospinal fluid (CSF) sampling showed raised WCC and a reduction in CSF glucose. No organism was grown, however both patients had commenced antibiotics prior to lumbar puncture. In both patients there was a purulent discharge at the epidural exit site, from which Staphylococcus aureus grew. Both patients were treated with a prolonged course of intravenous and oral antibiotics and recovered uneventfully.
DISCUSSION
Epidural space infection is an uncommon but serious complication of epidural anaesthesia. While the incidence of epidural abscess has been estimated to be between 0.2 and 1.2 per 10,000 hospital admissions 10 , the relationship to epidural catheterization itself is not known. There has been an increase in the number of reported cases of epidural abscess and meningitis associated with epidural anaesthesia in the recent literature 1 . It is not clear whether this is related to an increase in reporting, an overall increase in the total number of epidurals being performed or a true increase in infection rates. An incidence of one in 1930 epidural catheters based on a one-year prospective study has recently been reported 2 .
The mechanism responsible for development of epidural space infection is usually not clear. Causes may be classified as intrinsic or extrinsic 1 . Intrinsic mechanisms are generally related to the underlying health of the patient and include carcinoma, diabetes and depressed immune function. A review of 39 patients with spinal epidural abscess from all causes identified haematogenous spread as the cause in 26% of cases 10 , while there are reports where the same strain of bacteria was cultured from both a distant site and from the epidural space 11, 12 .
Extrinsic mechanisms include colonization of the entry site of the epidural catheter by bacteria and subsequent migration of bacteria along the catheter to gain access to the epidural space. Support for this mechanism is found in a review of 35 epidural abscesses following epidural anaesthesia with positive bacterial culture, which identified a Staphylococcus species in 83% of cases 3 . In a review of 15 cases of epidural abscess in association with longterm epidurals for chronic pain, four were associated with progressive inflammation of the tunnelled catheter tract 13 .
Previous work investigating infections with central venous catheters has demonstrated that most central venous catheter-related septicaemias begin with invasion of the transcutaneous insertion tract and thus heavy colonization of the insertion site is highly predictive of catheter-associated sepsis 4, 14 . Reducing bacterial colonization of the insertion site has been shown to reduce septicaemia. The use of chlorhexidine 2%, rather than 10% povidone-iodine or 70% alcohol, for cutaneous disinfection before insertion and for post-insertion site care of central venous catheters significantly reduced the incidence of catheter-related bacteraemia 5 . In addition, the use of dry gauze dressings compared to transparent dressings significantly reduced rates of insertion site colonization, local catheter-related infection and systemic catheter-related sepsis 6 .
Whereas there is no evidence that the results cited above can be extrapolated to epidural catheters, the overall low incidence of epidural abscesses ensures that it is very difficult to design an independent study of this problem that would have adequate statistical power. Attempts to reduce the risk of extrinsic factors such as colonization of the epidural site may nevertheless be prudent because of the high morbidity associated with epidural abscess.
An earlier study using a urethane composite dressing material to which chlorhexidine gluconate had been bound found that chlorhexidine was released in clinically effective concentrations for up to 10 days 8 . There was a biphasic delivery of chlorhexidine from the dressing with greater concentrations delivered on days 1 through 3, followed by steady state release approximating zero order kinetics on days 3 through 10. In that study, epidural catheter bacterial colonization was significantly reduced in the chlorhexidine group compared with the control group 8 . The reduction in epidural catheter colonization rate was similar to that found with the Biopatch group in our study. The Biopatch is a doughnut shaped foam disc, of 2.5 cm diameter, with a slit that enables it to be easily passed around the catheter when it is placed directly in contact with the skin at the exit site. Previous studies have suggested a higher epidural catheter infection rate with thoracic compared to lumbar epidural anaesthesia 15 . However a more recent prospective study of epidural abscesses following epidural catheterization found that thoracic epidural was not associated with an increased risk of abscess compared with the lumbar route 2 . In our study, the colonization rate of thoracic epidural sites was 47.6% compared with 20% in the lumbar area, but as there were only five patients in the lumbar group, we are unable to draw any conclusions.
Preliminary analysis suggested that epidural catheter site colonization was increased when trainees performed the procedure. However, after correcting for the higher percentage of catheters inserted by consultants in the Biopatch group, there was no significant difference when the operator was a trainee rather than a consultant anaesthetist. This suggests the reduction in colonization was due to the use of the Biopatch.
Despite a trend to longer duration of catheterization in the Biopatch group (P=0.05), the colonization rate of the epidural site was significantly lower in this group.
In the control group, as expected, inflammation of the exit wound exceeding 5 mm, with or without purulence, was significantly associated with bacterial colonization of the epidural exit site. Of interest, five patients who had no inflammation or inflammation of less than 5 mm nevertheless grew bacteria at the exit site. Although inspection of the back for any signs of inflammation or infection is an essential part of epidural care, this indicates that absence of inflammation does not guarantee the absence of a significant bacterial count. Evidence of inflammation or pus at the exit site should, however, prompt catheter removal.
In conclusion, there is increasing concern about infection following central neuraxial block. Although this condition is rare, the cause is often unclear. Amongst extrinsic causes, which are to some extent under anaesthetic control, tracking of bacteria along the epidural catheter appears to be an important mechanism. Thus the Biopatch, which significantly reduces bacterial colonization of the epidural exit site, may be useful in preventing this.
